참고문헌
- Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet 2016;387:1947-1956. https://doi.org/10.1016/S0140-6736(16)00271-3
- Marinos G, Eliades C, Raman Muthusamy V, Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis 2014;10:929-934. https://doi.org/10.1016/j.soard.2014.03.005
- Sampath K, Rothstein RI. Selected endoscopic gastric devices for obesity. Gastrointest Endosc Clin N Am 2017;27:267-275. https://doi.org/10.1016/j.giec.2017.01.005
- Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014;56:465-472. https://doi.org/10.1016/j.pcad.2013.09.005
- Telem DA, Talamini M, Shroyer AL, et al. Long-term mortality rates (>8-year) improve as compared to the general and obese population following bariatric surgery. Surg Endosc 2015;29:529-536. https://doi.org/10.1007/s00464-014-3714-4
- Bennett MC, Badillo R, Sullivan S. Endoscopic management. Gastroenterol Clin North Am 2016;45:673-688. https://doi.org/10.1016/j.gtc.2016.07.005
- Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 2017;152:1791-1801. https://doi.org/10.1053/j.gastro.2017.01.044
- Verlaan T, de Jong K, de la Mar-Ploem ED, Veldhuyzen EA, Mathus-Vliegen EM, Fockens P. Trans-oral endoscopic restrictive implant system: endoscopic treatment of obesity? Surg Obes Relat Dis 2016;12:1711-1718. https://doi.org/10.1016/j.soard.2016.02.027
- Verlaan T, Paulus GF, Mathus-Vliegen EM, et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video). Gastrointest Endosc 2015;81:312-320. https://doi.org/10.1016/j.gie.2014.06.017
- Sartoretto A, Sui Z, Hill C, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg 2018;28:1812-1821. https://doi.org/10.1007/s11695-018-3135-x
- Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017;27:2649-2655. https://doi.org/10.1007/s11695-017-2693-7
- Familiari P, Costamagna G, Blero D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc 2011;74:1248-1258. https://doi.org/10.1016/j.gie.2011.08.046
- Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008;40:406-413. https://doi.org/10.1055/s-2007-995748
- Kumar N. Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc 2015;7:847-859. https://doi.org/10.4253/wjge.v7.i9.847
- Hill C, Khashab MA, Kalloo AN, Kumbhari V. Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci 2018;1411:36-52. https://doi.org/10.1111/nyas.13441
- Miller K, Turro R, Greve JW, Bakker CM, Buchwald JN, Espinos JC. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy. Obes Surg 2017;27:310-322. https://doi.org/10.1007/s11695-016-2295-9
- Lopez-Nava G, Bautista-Castano I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis 2015;11:861-865. https://doi.org/10.1016/j.soard.2014.09.026
피인용 문헌
- Biomaterials in Gastroenterology: A Critical Overview vol.55, pp.11, 2019, https://doi.org/10.3390/medicina55110734